Sign inJoin waitlistJoin the waitlist

Raymond Wadlow

Physician · Inova Fair Oaks Hospital

Credentials: · · · · ·

History

Early Developmental Therapeutics · Inova Fairfax Hospital Campus
Present

Hematology and Medical Oncology
Dana-Farber Cancer Institute
2003–2006
Broad Institute
2001–2003
Internal Medicine
University of Pennsylvania Health System
2000–2001
University of Virginia School of Medicine
1996–2000

Research

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Nature · 2009 · 3,074 citations
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells
Cell · 2009 · 464 citations
A phase 1/2 and biomarker study of preoperative short course chemoradiation with proton beam therapy and capecitabine followed by early surgery for resectable pancreatic ductal…
International journal of radiation oncology · 2014 · 86 citations

David Ryan
8 papers
AZ
Andrew Zhu
7 papers
LB
Lawrence Blaszkowsky
7 papers
Eunice Kwak
6 papers
JA
Jill Allen
6 papers
TC
Timothy Cannon
5 papers
Arthur Winer
4 papers · 2 as a fellow
JC
Jeffrey Clark
4 papers
SR
Sridhar Ramaswamy
4 papers
Theodore Hong
4 papers
Thomas Abrams
4 papers
Brian Wolpin
3 papers

Clinical trials

Observational Study of ctDNA in Resectable and Borderline Resectable Pancreatic Cancer
Principal investigator · Withdrawn
Inova Health Care Services
2022–2023
A Systems Approach to Immunotherapy Biomarker Identification Within the Postoperative Wound-Healing Microenvironment in Patients With Gastroesophageal Cancer
Principal investigator · Completed
Inova Health Care Services
2022–2025
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Site PI · Recruiting · Phase 3
SWOG Cancer Research Network
2026–2030
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Site PI · Recruiting · Phase 1
NextCure, Inc.
2025–2026